title: Quantifying ligand bias at seven-transmembrane receptors.
abstract: Seven transmembrane receptors (7TMRs), commonly referred to as G protein-coupled receptors, form a large part of the "druggable" genome. 7TMRs can signal through parallel pathways simultaneously, such as through heterotrimeric G proteins from different families, or, as more recently appreciated, through the multifunctional adapters, β-arrestins. Biased agonists, which signal with different efficacies to a receptor's multiple downstream pathways, are useful tools for deconvoluting this signaling complexity. These compounds may also be of therapeutic use because they have distinct functional and therapeutic profiles from "balanced agonists." Although some methods have been proposed to identify biased ligands, no comparison of these methods applied to the same set of data has been performed. Therefore, at this time, there are no generally accepted methods to quantify the relative bias of different ligands, making studies of biased signaling difficult. Here, we use complementary computational approaches for the quantification of ligand bias and demonstrate their application to two well known drug targets, the β2 adrenergic and angiotensin II type 1A receptors. The strategy outlined here allows a quantification of ligand bias and the identification of weakly biased compounds. This general method should aid in deciphering complex signaling pathways and may be useful for the development of novel biased therapeutic ligands as drugs.
authors: Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
authors: Sudarshan
authors: S
authors: Rajagopal
authors: Seungkirl
authors: S
authors: Ahn
authors: David H
authors: DH
authors: Rominger
authors: William
authors: W
authors: Gowen-MacDonald
authors: Christopher M
authors: CM
authors: Lam
authors: Scott M
authors: SM
authors: Dewire
authors: Jonathan D
authors: JD
authors: Violin
authors: Robert J
authors: RJ
authors: Lefkowitz
references: Assay Drug Dev Technol. 2007 Jun;5(3):425-51
references: 17638542
references: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10782-7
references: 12949261
references: Br J Pharmacol. 2002 Apr;135(7):1715-22
references: 11934812
references: Mol Pharmacol. 2002 Apr;61(4):768-77
references: 11901215
references: J Biol Chem. 1989 Sep 5;264(25):14848-52
references: 2549039
references: Annu Rev Physiol. 2007;69:483-510
references: 17305471
references: Biochem Pharmacol. 1988 Nov 15;37(22):4289-97
references: 2848525
references: Sci Transl Med. 2009 Oct 7;1(1):1ra1
references: 20368153
references: J Biol Chem. 1980 Aug 10;255(15):7108-17
references: 6248546
references: Mol Pharmacol. 1998 Jul;54(1):94-104
references: 9658194
references: Br J Pharmacol Chemother. 1956 Dec;11(4):379-93
references: 13383117
references: Trends Pharmacol Sci. 1999 Oct;20(10):400-5
references: 10498953
references: Mol Pharmacol. 2011 Feb;79(2):298-307
references: 20978120
references: J Biol Chem. 2010 Apr 23;285(17):12522-35
references: 20189994
references: Mol Pharmacol. 2010 Oct;78(4):756-66
references: 20647394
references: Nat Rev Drug Discov. 2010 May;9(5):373-86
references: 20431569
references: Mol Pharmacol. 2007 Dec;72(6):1393-401
references: 17901198
references: Trends Mol Med. 2011 Mar;17(3):126-39
references: 21183406
references: J Pharmacol Exp Ther. 2009 Jan;328(1):331-42
references: 18824613
references: J Biol Chem. 2010 Mar 5;285(10):7459-74
references: 20051519
references: Mol Pharmacol. 2010 Sep;78(3):456-65
references: 20547734
references: Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):64-9
references: 18165312
references: Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62
references: 6141562
references: Pharmacol Rev. 2010 Jun;62(2):265-304
references: 20392808
references: ACS Chem Biol. 2008 Jun 20;3(6):346-51
references: 18570354
references: J Biol Chem. 2010 Nov 12;285(46):36188-98
references: 20837485
references: Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16284-9
references: 17060617
references: Mol Pharmacol. 2006 Nov;70(5):1575-84
references: 16901982
references: Trends Pharmacol Sci. 1995 Jul;16(7):232-8
references: 7667897
references: J Biol Chem. 2006 Apr 21;281(16):10856-64
references: 16492667
references: J Biol Chem. 2008 Feb 29;283(9):5669-76
references: 18086673
references: Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):549-77
references: 18253722
references: J Pharmacol Exp Ther. 2010 Dec;335(3):572-9
references: 20801892
references: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62
references: 17925438